You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Platinum-containing doublet

Showing 1 - 25 of 7,090
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Limited Stage Small Cell Lung Cancer Trial in Shang'ai (chemo and SHR-1316(Adebrelimab) comnined with surgery or radiotherapy)

Not yet recruiting
  • Limited Stage Small Cell Lung Cancer
  • chemotherapy and SHR-1316(Adebrelimab) comnined with surgery or radiotherapy
  • Shang'ai, Shanghai, China
    Shanghai Pulmonary Hospital
Aug 8, 2022

Mesothelioma, Malignant, Mesothelioma, Malignant Pleural, Mesothelioma Malignant Advanced Trial in Beijing

Not yet recruiting
  • Mesothelioma, Malignant
  • +2 more
  • Beijing, China
    Cancer Hospital Chinese Academy of Medical Sciences
Dec 27, 2021

NSCLC (NSCLC) Trial (Sotorasib, Pembrolizumab)

Not yet recruiting
  • Non-Small Cell Lung Cancer (NSCLC)
  • (no location specified)
Jun 26, 2023

NSCLC Trial in Tianjing (Envalfolimab subcutaneously injected+Platinum-based doublet chemo intravenous injection,

Not yet recruiting
  • Non-small Cell Lung Cancer
  • Envalfolimab subcutaneously injected+Platinum-based doublet chemotherapy intravenous injection
  • placebo subcutaneously injected +Platinum-based doublet chemotherapy intravenous injection
  • Tianjing, Tianjin, China
    Tianjin cancer hospital
Nov 3, 2023

Platinum-resistant Ovarian Cancer, Platinum-refractory Ovarian Cancer, Fallopian Tube Cancer Trial in Orlando, Albuquerque

Recruiting
  • Platinum-resistant Ovarian Cancer
  • +6 more
  • olvimulogene nanivacirepvec
  • +3 more
  • Orlando, Florida
    AdventHealth Cancer Institute
Sep 1, 2022

Locally Advanced NSCLC Trial in Beijing (Toripalimab combination with platinum-containing dual-drug chemo.)

Recruiting
  • Locally Advanced NSCLC
  • Toripalimab combination with platinum-containing dual-drug chemotherapy.
  • Beijing, Beijing, China
    Beijing Cancer Hospital
Nov 25, 2020

NSCLC Trial in Tampa, Philadelphia (Durvalumab, Carboplatin, Abequolixron)

Not yet recruiting
  • Non-Small Cell Lung Cancer
  • Tampa, Florida
  • +1 more
Jun 9, 2023

NSCLC (NSCLC) Trial (Ociperlimab, Placebo, Tislelizumab)

Not yet recruiting
  • Non-small Cell Lung Cancer (NSCLC)
  • (no location specified)
Mar 17, 2023

Carcinoma, Small Cell Lung Trial in United States (RRx-001 + eLOOP Device, Cisplatin/carboplatin plus etoposide)

Active, not recruiting
  • Carcinoma, Small Cell Lung
  • RRx-001 + eLOOP Device
  • Cisplatin/carboplatin plus etoposide
  • Tampa, Florida
  • +5 more
Oct 3, 2022

Advanced Lung Squamous Cell Carcinoma Trial in Chengdu (low-dose radiation therapy and stereotactic body radiation therapy,

Not yet recruiting
  • Advanced Lung Squamous Cell Carcinoma
  • low-dose radiation therapy and stereotactic body radiation therapy
  • +2 more
  • Chengdu, Sichuan, China
    West China Hospital of Sichuan University
Nov 13, 2023

Stage II-III NSCLC Trial in Shanghai (4cycles(Toripalimab IV 240mg + platinum-based doublet chemo)+13 cycles(Toripalimab IV

Recruiting
  • Stage II-III Non-small Cell Lung Cancer
  • 4cycles(Toripalimab IV 240mg + platinum-based doublet chemotherapy)+13 cycles(Toripalimab IV 240mg); Biological: Toripalimab
  • 4cycles(Placebo + platinum-based doublet chemotherapy)+13 cycles(Placebo )
  • Shanghai, China
    Shanghai Chest Hospital
Apr 12, 2022

Locally Advanced, NSCLC Trial in Shanghai (drug, procedure, radiation)

Recruiting
  • Locally Advanced
  • Non-small Cell Lung Cancer
  • Shanghai, China
    Shanghai Pulmonary Hospital
Mar 14, 2023

Oral Squamous Cell Carcinoma Trial (Three-Week Treatment Regimen with Trastuzumab in Combination with Docetaxel and Platinum

Not yet recruiting
  • Oral Squamous Cell Carcinoma
  • Three-Week Treatment Regimen with Trastuzumab in Combination with Docetaxel and Platinum Triple Therapy
  • (no location specified)
Nov 11, 2023

Stage III NSCLC Trial (Toripalimab, JS004, Pemetrexed)

Not yet recruiting
  • Stage III Non-small Cell Lung Cancer
  • (no location specified)
Jun 3, 2023

Carcinoma, Small Cell Lung Trial in United States (RRx-001 + eLOOP Device, Cisplatin/carboplatin plus etoposide)

Terminated
  • Carcinoma, Small Cell Lung
  • RRx-001 + eLOOP Device
  • Cisplatin/carboplatin plus etoposide
  • Denver, Colorado
  • +17 more
Sep 30, 2022

NSCLC, Stage III Trial in Beijing (Tislelizumab, Pemetrexed (Nonsquamous NSCLC) or Paclitaxel/Nab-paclitaxel(Squamous NSCLC),

Recruiting
  • NSCLC, Stage III
  • Beijing, Beijing, China
    Beijing Tsinghua Chang Gung Hospital
Nov 4, 2022

Persistent, Recurrent, or Metastatic Cervical Cancer Trial in Shanghai (GLS-010, Placebo, paclitaxel)

Not yet recruiting
  • Persistent, Recurrent, or Metastatic Cervical Cancer
  • Shanghai, Shanghai, China
    Fudan University Shanghai Cancer Hospital
Apr 4, 2023

Advanced Non-squamous Non-small-cell Lung Cancer, Recurrent Non-Squamous NSCLC, Metastatic Non-squamous Non Small Cell Lung

Not yet recruiting
  • Advanced Non-squamous Non-small-cell Lung Cancer
  • +2 more
  • Beijing, Beijing, China
    Peking University First Hospital Ethics Committee
Sep 10, 2023

Lung Adenocarcinoma Trial in Shijiazhuang (Tislelizumab,Platinum)

Recruiting
  • Lung Adenocarcinoma
  • Shijiazhuang, Hebei, China
    The Fourth Hospital of Hebei Medical University (Hebei Tumor Hos
Sep 24, 2023

Metastatic Non-Small Lung Cell Cancer, Recurrent Non-Small Lung Cell Cancer, Stage IV Lung Cancer AJCC v8 Trial in Atlanta

Recruiting
  • Metastatic Non-Small Lung Cell Cancer
  • +4 more
  • Atlanta, Georgia
    Winship Cancer Institute of Emory University
Oct 19, 2022

NSCLC Trial in Saint Petersburg, Cremona, Vilnius (REGN2810/ipi, REGN2810/chemo/ipi, Pembrolizumab)

Terminated
Has Results
  • Non-small Cell Lung Cancer
  • Saint Petersburg, Florida
  • +2 more
Oct 22, 2022

Small Cell Carcinoma, NSCLC, Neuroendocrine Tumors Trial in United States (RRx-001, Cisplatin, Etoposide)

Active, not recruiting
  • Small Cell Carcinoma
  • +3 more
  • Palo Alto, California
  • +9 more
May 12, 2022

Non Small Cell Lung Cancer Metastatic Trial (Pembrolizumab in Combination with Plinabulin and Docetaxel)

Not yet recruiting
  • Non Small Cell Lung Cancer Metastatic
  • Pembrolizumab in Combination with Plinabulin and Docetaxel
  • (no location specified)
Oct 28, 2022

NSCLC Trial in Philadelphia (device, drug, other)

Not yet recruiting
  • NSCLC
  • Aliya Pulsed Electric Fields (PEF) ablation
  • +3 more
  • Philadelphia, Pennsylvania
    Temple University
Oct 24, 2022

Non-small-cell Lung Cancer Patients Trial in Roma (Durvalumab, Olaparib tablet, Single-agent chemo)

Recruiting
  • Non-small-cell Lung Cancer Patients
  • Roma, RM, Italy
    Istituti Fisioterapici Ospitalieri- Ifo - Istituto Regina Elena
Sep 30, 2022